IDT Australia announces CEO resignation, trading update
IDT Australia, an ASX-listed pharmaceutical contract development and manufacturing organisation (CDMO), has announced the resignation of CEO Paul McDonald “with immediate effect”. According to a statement from the company on Thursday, current Independent Non-Executive Chair Mark Simari, who has been on the board since 2022, is now Executive Chair. The search for a new CEO will…
